An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.
Activity in China's critical manufacturing sector fell to its lowest level in three years in February, weighed on by weak global demand and the long Lunar New Year holiday.
